1-4 of 4
Peter L. Bergsagel
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Once- versus twice-weekly bortezomib induction therapy with CyBorD in newly diagnosed multiple myeloma

Craig B. Reeder, Donna E. Reece, Vishal Kukreti, Christine Chen, Suzanne Trudel, Kristina Laumann, Joseph Hentz, Nicholas A. Pirooz, Jesus G. Piza, Rodger Tiedemann, Joseph R. Mikhael, Peter L. Bergsagel, Jose F. Leis, Rafael Fonseca, Alexander K. Stewart
Journal: Blood
Blood (2010) 115 (16): 3416–3417.
https://doi.org/10.1182/blood-2010-02-271676
Published: 2010
Journal Articles

Ectopic Fibroblast Growth Factor Receptor 3 (FGFR3) Expression Mediated by Isotype Switch Recombination.

Maurizio Affer, Phd, Davide Robbiani, MD, Marta Chesi, Phd, Peter L. Bergsagel, MD
Journal: Blood
Blood (2004) 104 (11): 78.
https://doi.org/10.1182/blood.V104.11.78.78
Published: 2004
Journal Articles

Dysregulation of MMSET Is Tumorigenic In-Vivo.

Marta Chesi, PhD, Kruti Naik, MSc, Davide F. Robbiani, MD, Maurizio Affer, PhD, Helen D. Nickerson, PhD, Peter L. Bergsagel, MD
Journal: Blood
Blood (2004) 104 (11): 74.
https://doi.org/10.1182/blood.V104.11.74.74
Published: 2004
Journal Articles

Depsipeptide in the Treatment of Relapsed and Refractory Multiple Myeloma (MM): A Prospective Evaluation of the Cell Cycle.

Zoe Goldberg*, MD, Scott Ely, MD, Selina Chen-Kiang, PhD, Martha Chesi, PhD, Peter L. Bergsagel, MD, Karen Pekle*, RN, Larry Lyons*, Udi Gelbshtein*, Roger Pearse, MD, PhD, John Harpel, MD, PhD, Hearn Cho, MD, PhD, Morton Coleman, MD, Ruben Niesvizky, MD
Journal: Blood
Blood (2004) 104 (11): 1497.
https://doi.org/10.1182/blood.V104.11.1497.1497
Published: 2004